Get the Stockscreener App
2.28
2.56%
-0.06
Zura Bio Ltd stock is traded at $2.28, with a volume of 1.37M.
It is down -2.56% in the last 24 hours and down -21.38% over the past month.
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.
See More
Previous Close:
$2.34
Open:
$2.31
24h Volume:
1.37M
Relative Volume:
2.91
Market Cap:
$148.87M
Revenue:
-
Net Income/Loss:
$-60.36M
P/E Ratio:
-0.5445
EPS:
-4.1875
Net Cash Flow:
$-15.05M
1W Performance:
+0.00%
1M Performance:
-21.38%
6M Performance:
-34.10%
1Y Performance:
-52.80%
1-Day Range:
$2.16
$2.40
1-Week Range:
$2.155
$2.66
52-Week Range:
$2.00
$6.35
Zura Bio Ltd Stock (ZURA) Company Profile
Name
Zura Bio Ltd
Sector
Industry
Phone
858-247-0520
Address
4225 EXECUTIVE SQUARE, LA JOLLA
Compare ZURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZURA
Zura Bio Ltd
|
2.28 | 148.87M | 0 | -60.36M | -15.05M | -4.394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-24 | Initiated | Leerink Partners | Outperform |
| Sep-05-24 | Initiated | H.C. Wainwright | Neutral |
| May-03-24 | Initiated | Piper Sandler | Overweight |
| Oct-10-23 | Initiated | Ladenburg Thalmann | Buy |
| Aug-25-23 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Guggenheim | Buy |
| Jun-14-23 | Initiated | Chardan Capital Markets | Buy |
| May-24-23 | Initiated | Raymond James | Strong Buy |
View All
Zura Bio Ltd Stock (ZURA) Latest News
17,442 Shares in Zura Bio Limited (NASDAQ:ZURA) Acquired by The Manufacturers Life Insurance Company - Defense World
Zura Bio FY2025 EPS Forecast Increased by Leerink Partnrs - Defense World
Zura Bio FY2025 EPS Forecast Boosted by Leerink Partnrs - MarketBeat
Zura Bio Limited (NASDAQ:ZURA) Receives $15.80 Average PT from Analysts - Defense World
Zura Bio Limited (NASDAQ:ZURA) Receives $15.80 Average Target Price from Analysts - MarketBeat
Zura Bio Limited (NASDAQ:ZURA) Short Interest Update - Defense World
Zura Bio : to Present at the Piper Sandler 36th Annual Healthcare Conference Form 8 K - Marketscreener.com
Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference - Yahoo Finance
We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely - Simply Wall St
HC Wainwright Reaffirms "Neutral" Rating for Zura Bio (NASDAQ:ZURA) - MarketBeat
GREAT POINT PARTNERS LLC Reduces Stake in Zura Bio Ltd - GuruFocus.com
ADAR1 Capital Management, LLC Acquires New Stake in Zura Bio Ltd - GuruFocus.com
Zura Bio advances Phase 2 study for systemic sclerosis treatment - Investing.com
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis - Yahoo Finance
HC Wainwright Has Positive Outlook for Zura Bio Q3 Earnings - MarketBeat
Guggenheim maintains Buy on Zura Bio, target steady at $15 - Investing.com India
Guggenheim maintains Buy on Zura Bio, target steady at $15 By Investing.com - Investing.com UK
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - BioSpace
Q3 Earnings Forecast for Zura Bio Issued By Leerink Partnrs - MarketBeat
Zura Bio (NASDAQ:ZURA) Stock Rating Upgraded by Leerink Partnrs - Defense World
Piper Sandler sets price target on Zura Bio shares, cites positive trial data - Investing.com
Leerink Partners initiates Zura Bio stock with Outperform rating, $15 target - Investing.com
Zura Bio Ltd re-elects board, ratifies auditor at AGM By Investing.com - Investing.com Australia
Zura Bio to Participate in Two Upcoming Investor Conferences in November - Yahoo Finance
Zura Bio Ltd re-elects board, ratifies auditor at AGM - Investing.com India
Zura Bio announces departure of Chief Scientific Officer By Investing.com - Investing.com Australia
Zura Bio announces departure of Chief Scientific Officer - Investing.com India
Private equity firms among Zura Bio Limited's (NASDAQ:ZURA) largest shareholders, saw gain in holdings value after stock jumped 14% last week - Simply Wall St
Forefront Analytics LLC Has $145,000 Holdings in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Zura Bio Limited (NASDAQ:ZURA) Shares Sold by Affinity Asset Advisors LLC - Defense World
Should investors be concerned about Zura Bio Ltd (ZURA)? - US Post News
A stock that deserves closer examination: Zura Bio Ltd (ZURA) - US Post News
Institutions profited after Zura Bio Limited's (NASDAQ:ZURA) market cap rose US$45m last week but private equity firms profited the most - Yahoo Finance
Piper Sandler maintains Overweight rating on Zura Bio shares - Investing.com
Zura Bio Ltd [ZURA] Director makes an insider sale of 3,800,000 shares worth 10,260,000. - Knox Daily
Piper Sandler maintains Overweight rating on Zura Bio shares By Investing.com - Investing.com Australia
Zura Bio Ltd (ZURA) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Zura Bio (NASDAQ:ZURA) versus Aligos Therapeutics (NASDAQ:ALGS) Critical Comparison - Defense World
A Guide To The Risks Of Investing In Zura Bio Ltd (ZURA) - Knox Daily
Have Zura Bio Insiders Been Selling Stock? - Simply Wall St
Zura Bio director Sidhu Someit sells shares worth over $200,000 - Investing.com
Taking a look at what insiders are doing to gauge the Zura Bio Ltd (ZURA)’s direction - Knox Daily
Zura Bio to Present at Three Upcoming Investor Conferences in September - Yahoo Finance
Zura Bio Ltd [ZURA] Stock bought by Insider Ploos van Amstel Arnout for $0.5 million - Knox Daily
Get in on Zura Bio Ltd’s (ZURA) buy-in window today! - SETE News
Zura Bio Ltd (ZURA) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Zura Bio issues warrants after share surrender - Investing.com India
Zura Bio Ltd Stock (ZURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zura Bio Ltd Stock (ZURA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Thiara Parvinder | Director |
Sep 11 '24 |
Sale |
2.70 |
3,800,000 |
10,260,000 |
1,001,633 |
| Sidhu Someit | Director |
Sep 04 '24 |
Sale |
3.87 |
51,728 |
200,187 |
2,085,418 |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):